Accessibility

A+ A A-

Information Accessibility Statement
Site Colors Display (* Modern browsers like Chrome & Firefox) Normal Display Adjusted for color blinded Adjusted for hard vision Close
עב
En
عر
Pу
image/svg+xml
Find a Doctor
Find a Doctor
Service Center
Service Center
Orientation
Orientation
Donate
Donate
Schedule appointment
Sheba - English / Research / Research centers / The Research Center of Leukemia and Childhood Malignancies / Research Topics / Selected publications

Selected publications

  1. Izraeli, S., Trisomy 21 tilts the balance. Blood, 2008. 112(12): p. 4361-2.

  2. Malinge, S., S. Izraeli, and J.D. Crispino, Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood, 2009. 113(12): p. 2619-28.

  3. Rainis, L., D. Bercovich, S. Strehl, A. Teigler-Schlegel, B. Stark, J. Trka, N. Amariglio, A. Biondi, I. Muler, G. Rechavi, H. Kempski, O.A. Haas, and S. Izraeli, Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood, 2003. 102(3): p. 981-6.

  4. Rainis, L., T. Toki, J.E. Pimanda, E. Rosenthal, K. Machol, S. Strehl, B. Gottgens, E. Ito, and S. Izraeli, The Proto-Oncogene ERG in Megakaryoblastic Leukemias. Cancer Res, 2005.65(17): p. 7596-7602.

  5. Salek-Ardakani, S., G.Smooha, J. de Boer, N.J. Sebire, M. Morrow, L. Rainis, S. Lee, O. Williams, S. Izraeli, and H.J. Brady, ERG is a megakaryocytic oncogene. Cancer Res, 2009.69(11): p. 4665-73.

  6. Bercovich, D., I. Ganmoe, L.M. Scott, G. Wainreb, Y. Birger, A. Elimelech, C. Shochat, G. Cazzaniga, A. Biondi, G. Basso, G. Cario, M. Schrappe, M. Stanulla, S. Strehl, O.A. Haas, G. Mann, V. Binder, A. Borkhardt, H. Kempski, J. Trka, B. Bielorei, S. Avigad, B. Stark, O. Smith, N. Dastugue, J.P. Bourquin, N.B. Tal, A.R. Green, and S. Izraeli, Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet, 2008. 372(9648): p. 1484-92.

  7. Ganmore, I., G. Smooha, and S. Izraeli, Constitutional aneuploidy and cancer predisposition. Hum Mol Genet, 2009. 18(R1): p. R84-93.

  8. Grinberg-Rashi, H., E. Ofek, M. Perelman, J. Skarda, P. Yaron, M. Hajduch, J. Jacob-Hirsch, N. Amariglio, M. Krupsky, D.A. Simansky, Z. Ram, R. Pfeffer, I. Galernter, D.M. Steinberg, I. Ben-Dov, G. Rechavi, and S. Izraeli, The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res, 2009.15(5): p. 1755-61.

  9. Cario, G., S. Izraeli, A. Teichert, P. Rhein, J. Skokowa, A. Moricke, M. Zimmermann, A. Schrauder, L. Karawajew, W.D. Ludwig, K. Welte, H.J. Schunemann, B. Schlegelberger, M. Schrappe, and M. Stanulla, High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol, 2007. 25(30): p. 4813-20.

  10. Izraeli, S., L.A. Lowe, V.L. Bertness, D.J. Good, D.W. Dorward, I.R. Kirsch, and M.R.Kuehn, The SIL gene i required for mouse embryonic axial development and left- right specification. Nature, 1999. 399(6737): p. 691-4.

  11. Erez, A., A. Castiel, L. Trakhtenbrot, M. Perelman, E. Rosenthal, I. Goldstein, N. Stettner, A. Harmelin, H. Eldar-Finkelman, S. Campaner, I. Kirsch, and S. Izraeli, The SIL gene is essential for mitotic entry and survival of cancer cells. Cancer Res, 2007. 67(9): p. 4022-7.

  12. Erez, A., M. Perelman, S.M. Hewitt, G. Cojacaru, I. Goldberg, I. Shahar, P. Yaron, I. Muler, S. Campaner, N. Amariglio, G. Rechavi, I.R. Kirsch, M. Krupsky, N. Kaminski, and S. Izraeli, Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene, 2004. 23(31): p. 5371-7.

  13. Izraeli, S., L.A. Lowe, V.L. Bertness, S. Campaner, H. Hahn, I.R. Kirsch, and M.R. Kuehn, Genetic evidence that Sil is required for the Sonic Hedgehog response pathway. Genesis, 2001. 31(2): p. 72-7

  14. Hochman, E., A. Castiel, J. Jacob-Hirsch, N. Amariglio, and S. Izraeli, Molecular Pathways Regulating Pro-migratory Effects of Hedgehog Signaling. J Biol Chem, 2006. 281(45): p. 33860-70.

  15. Hochman, E., S. Kinston, A. Harmelin, B. Gottgens, and S. Izraeli, The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification. Exp Hematol, 2006.34(12): p. 1643-50.

  16. Hertzberg, L., D.R. Betts, S.C. Raimondi, B.W. Schafer, D.A. Notterman, E. Domany, and S. Izraeli, Prediction of chromosomal aneuploidy from gene expression data. Genes Chromosomes Cancer, 2007. 46(1): p. 75-86

  17. Izraeli, S., L. Rainis, L. Hertzberg, G. Smooha, and Y. Birger, Trisomy of chromosome 21 in leukemogenesis. Blood Cells, Molecules, and Diseases, 2007. 39(2): p. 156-159.

  18. Erez, A., M. Chaussepied, A. Castiel, T. Colaizzo-Anas, P.D. Aplan, D. Ginsberg, and S. Izraeli, The mitotic checkpoint gene, SIL is regulated by E2F1. Int J Cancer, 2008. 123(7): p. 1721-5.

מוקד שירות אנגלית
Quality Metrics
donation - אתר אנגלית
MOVIES - אתר אנגלית